Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (361-370 of 511) with videos related to

Pageof 52
Sort By:
Diabetes|May 27, 2003
Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD miceCarlos Penha-Gonçalves, Carolyn Moule, Luc J Smink, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibChee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Annals of Surgical Oncology|October 29, 2014
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaOliver M Fisher, Angelique J Levert-Mignon, Sarah J Lord, et al.
Annals of Surgical Oncology|February 10, 2022
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III MelanomaMbathio Dieng, Sarah J Lord, Robin M Turner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Nucleic Acids Research|May 11, 2012
Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationSimon S McDade, Alexandra E Henry, Geraldine P Pivato, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
The Journal of Cell Biology|September 19, 2019
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survivalCrystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, et al.
Nature Methods|May 8, 2019
Epi-illumination SPIM for volumetric imaging with high spatial-temporal resolutionBin Yang, Xingye Chen, Yina Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase InhibitorAngelina Tjokrowidjaja, M L Friedlander, Jonathan A Ledermann, et al.
Pageof 52

Showing results (361-370 of 511) with videos related to

Sort By:
Pageof 52
Diabetes|May 27, 2003
Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD miceCarlos Penha-Gonçalves, Carolyn Moule, Luc J Smink, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibChee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Annals of Surgical Oncology|October 29, 2014
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaOliver M Fisher, Angelique J Levert-Mignon, Sarah J Lord, et al.
Annals of Surgical Oncology|February 10, 2022
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III MelanomaMbathio Dieng, Sarah J Lord, Robin M Turner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Nucleic Acids Research|May 11, 2012
Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationSimon S McDade, Alexandra E Henry, Geraldine P Pivato, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
The Journal of Cell Biology|September 19, 2019
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survivalCrystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, et al.
Nature Methods|May 8, 2019
Epi-illumination SPIM for volumetric imaging with high spatial-temporal resolutionBin Yang, Xingye Chen, Yina Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase InhibitorAngelina Tjokrowidjaja, M L Friedlander, Jonathan A Ledermann, et al.
Pageof 52